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Abstract The combination of isotretinoin (13-cis-retinoic
acid) with antiestrogens seems to be a promising strategy
for cancer chemotherapy. The aim of the study was to
evaluate the effects of isotretinoin alone or in combina-
tion with 4-hydroxytamoxifen (OHTAM) and with its
prodrug tamoxifen (TAM), on the functions of rat liver
mitochondria, i.e., mitochondrial permeability transition
(MPT), bioenergetic functions and adenine nucleotide
translocase (ANT). Isotretinoin (5 nmol/mg protein) in-
duced the Ca2+-dependent MPT pore opening in mito-
chondria energized with succinate, which was prevented
by OHTAM, cyclosporine A, TAM and ANT ligands.
When mitochondria were energized with glutamate/malate
and in the absence of added Ca2+ isotretinoin decreased
the state 3 respiration, the ATP levels, the active ANT
content and increased the lag phase of the phosphoryla-
tion cycle, demonstrating that isotretinoin decreased the
mitochondrial phosphorylation efficiency. These changes
of isotretinoin in bioenergetic parameters were not signif-
icant in the presence of succinate. The effects of isotret-
inoin at 5 nmol/mg protein on the Ca2+-dependent MPT
and phosphorylative efficacy may be related with inter-
actions with the ANT. Above 10 nmol/mg protein iso-
tretinoin strongly diminished the active ANT content,
decreased the Δψ, inhibited the complex I and induced
proton leak through the Fo fraction of complex V. The
combination of OHTAM with isotretinoin only induced sig-
nificant changes in the energy production systems at concen-
trations ≥5 nmol isotretinoin/mg protein. Therefore, our results
suggest that isotretinoin-associated liver toxicity is possibly
related with mitochondrial dysfunctions and that the combina-
tion with OHTAM may contribute to decrease its toxicity.
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Abbreviations
ANT Adenine nucleotide translocase
Asc Ascorbate
CAT Carboxyatractyloside
CyA Cyclosporine A
Cys Cysteine
DTT Dithiothreitol
FCCP Carbonyl cyanide p-
trifluormethoxyphenylhydrazone
MPT Mitochondrial permeability transition
NAC N-acetylcysteine
NEM N-ethylmaleimide
OHTAM 4-hydroxytamoxifen
TAM Tamoxifen
TPP+ Tetraphenylphosphonium
RAR Retinoic acid receptor
RCR Respiratory control ratio
RXR Retinoid X receptor
Δ= Mitochondrial membrane potential
Introduction
Isotretinoin (13-cis-retinoic acid), structurally related to vita-
min A, is a first-generation retinoid often used for the treatment
of many inflammatory skin disorders, and its use in the treat-
ment of some cancers is currently under investigation (Njar et
al. 2006; Norris et al. 2011; Pili et al. 2012). This compound
achieves its remarkable efficacy by interfering with cell-cycle
progression, cellular differentiation, cell survival and apoptosis
in different cell types, including human breast cancer cells
(Toma et al. 1997; Czeczuga-Semeniuk et al. 2001), hepatoma
(Arce et al. 2005) and melanoma cells (Lotan et al. 1980; Niu
et al. 2005; Guruvayoorappan et al. 2008). It has been de-
scribed that the inhibition of cancer cell growth by isotretinoin
is mediated through the nuclear retinoid receptors, i.e., retinoic
acid receptor (RAR) and retinoid X receptor (RXR) (Chambon
1996). However, it has been hypothesized that isotretinoin acts
independently of the nuclear retinoid receptor pathway
(Sabichi et al. 2003), as suggested by the multiple side effects
observed in patients treated with isotretinoin (Goodfield et al.
2010; Sardana & Garg 2011). In addition, cell culture studies
showed that isotretinoin induces several changes in mitochon-
dria, such as a decrease in the expression of the antiapoptotic
protein Bcl-2 (Guruvayoorappan et al. 2008; Vuletic et al.
2010) and the activation of caspase-3 (Arce et al. 2005;
Guruvayoorappan et al. 2008) leading to cell death by apopto-
sis. It was also reported that isotretinoin (at concentrations
from 4 to 33 μM or 16 to 132 nmol/mg protein) induces
mitochondrial permeability transition (MPT) pore opening
and the release of the cytochrome c (Rigobello et al. 1999).
These results suggest that mitochondria may be involved in
the toxicological effects induced by this retinoid.
The RARs are members of the thyroid-retinoid receptors
family and have a basic structure that is also present in other
nuclear receptors, such as the estrogen receptors (ER)
(Chambon 1996). It has been proposed that both RAR and
ER take part of a “cross talk” pathway, as the inhibition of
breast tumor cell growth by retinoids is more pronounced
for ER-positive cells (Simeone & Tari 2004). Furthermore,
RAR activated appear to exert anti-estrogenic effects by
directly or indirectly link the ER to estrogen response
elements (EREs) (Demirpence et al. 1994). Conversely,
the N-terminal region of ERα modulates the transcriptional
activity of RAR (Rousseau et al. 2003). More recently,
different works have demonstrated that retinoic acid recep-
tor α (RARα) is probably an essential component of the ER
(Ross-Innes et al. 2010), and that these two nuclear recep-
tors cooperate for effective transcriptional activity in breast
cancer cells (Ross-Innes et al. 2010; Hua et al. 2009). These
findings suggest the existence of an interplay between ret-
inoid and estrogen signaling, and that the combination of
isotretinoin with antiestrogenic compounds may be a prom-
ising therapy. In fact, it has been observed a synergistic
action between retinoids and tamoxifen (TAM), a non-
steroidal antiestrogenic compound, on breast cancer cell
death (Saez et al. 2003; Wang et al. 2007; Searovic et al.
2009). However, TAM is a prodrug with serious side effects
(Wong & Ellis 2004) and patients present a large variation
in both therapeutic efficacy and side effects due to CYP3A4
and CYP2D6 polymorphisms (Damodaran et al. 2012). 4-
hydroxytamoxifen (OHTAM), a major active metabolite,
responsible for the anticancer activity of TAM, is a prom-
ising compound since this metabolite has a higher affinity
for ER, and it is 30- to 200-times more potent than TAM
(Lim et al. 2005; Kiyotani et al. 2012). In addition, it is
pharmacologically well tolerated (Sauvez et al. 1999) and
has less side effects (Cardoso et al. 2002a; Cruz Silva et al.
2001). However, although the combined therapy of anties-
trogens with isotretinoin seems to be a good strategy for
cancer treatment, the effects of this retinoid in combination
with OHTAM or TAM on mitochondria have not been
studied.
Considering that mitochondrial damage is a triggering
event for deregulation of cell homeostasis (Lemasters et al.
2009; Starkov 2010; Wallace 2008; Fulda et al. 2010),
mitochondria fractions are a useful in vitro model to inves-
tigate drug toxicity/safety (Labbe et al. 2008). Therefore, the
purpose of this study was to evaluate the combined action of
OHTAM or TAM with isotretinoin on rat liver mitochondria
and the ability of OHTAM and TAM to prevent isotretinoin-
induced MPT and bioenergetic dysfunction. This study may
contribute to clarify the mechanisms of apoptosis and hep-
atotoxicity promoted by isotretinoin that must always be
considered during drug development and even for drugs
under therapeutic use (Labbe et al. 2008).
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Materials and methods
Isolation of rat liver mitochondria
Mitochondria were isolated from the liver of Wistar rats by
differential centrifugation as described elsewhere (Gazotti et
al. 1979), with slight modifications (Moreira et al. 2006).
Rats were killed by cervical dislocation, and their liver was
immediately excised and cooled at 4 °C in the homoge-
nization medium containing 250 mM sucrose, 10 mM
4-(2-hydroxymethyl)-1-piperazineethanesulfonic acid (HEPES)
(pH 7.4), 1 mMNNN′N-tetraacetic acid (EGTA) and 0.1% (w/v)
bovine serum albumin (BSA) fat-free. The homogenate
was centrifuged at 800×g for 10 min and mitochondria
were recovered from the supernatant by centrifugation at
10 000×g for 10 min. The EGTA was omitted from the
final washing medium and the final mitochondrial pellet
was washed twice. Mitochondrial protein concentration
was determined by the biuret method using BSA as the
protein standard (Gornall et al. 1949).
Mitochondrial membrane potential (Δ=)
The mitochondrial membrane potential (Δ=) was mon-
itored by evaluating the transmembrane distribution of
tetraphenylphosphonium (TPP+) with an ion-selective
electrode, prepared according to Kamo et al. (1979),
and using a Ag/AgCl2 electrode as reference (model
MI 402; Microelectrodes, Inc., Bedford, NH). The Δ= was
estimated from the following equation: Δ==59×log (v/V) –
59×log (10ΔE/59−1), where v, V, and ΔE stand for inner
mitochondrial volume, incubation medium volume, and de-
flection of the electrode potential from the baseline, respec-
tively. A matrix volume of 1.1 μl/mg of protein was assumed.
To monitor Δ= associated to mitochondrial respiration, liver
mitochondria (1 mg) were incubated at 30 °C for 3 min, in
2 ml of standard respiratory reaction medium (130 mM su-
crose, 50 mM KCl, 5 mM MgCl2, 0.1 mM EGTA, 5 mM
KH2PO4, 5 mM Hepes, pH 7.4) supplemented with 4 μM
TPP+ prior to the addition of 5 mM glutamate/2.5 mMmalate
or 5 mM succinate to energize mitochondria. Isotretinoin was
added to the medium after protein addition and incubated for
2 min before starting the reactions. After steady-state distri-
bution of TPP+, ADP (150 nmol/mg protein) was added to
initiate state 3 respiration. Δ= was estimated from the de-
crease of TPP+ concentration in the reaction medium.
The Δ= associated to MPT induction was determined
with mitochondria (0.5 mg/ml) incubated in 2 ml of MPT
reaction medium (200 mM sucrose, 10 mM Tris-Mops,
1 mM KH2PO4 and 10 μM EGTA, pH 7.4) supplemented
with 4 μM TPP+ and 2 μM rotenone in the absence and in
the presence of 1 μM cyclosporine A (CyA), thiol protecting
and antioxidant agents [1 mM dithiothreitol (DTT), 50 μM
N-ethylmaleimide (NEM), 200 μM cysteine (Cys), 200 μM
N-acetylcysteine (NAC), 1 mM ascorbate (Asc) and 1 mM
glutathione (GSH)], ANT ligands [ADP (75 μM) and ATP
(150 μM)] and antiestrogenic compounds [TAM and OHTAM
(5 μM)] before the addition of 5 nmol isotretinoin/mg protein.
Mitochondria were energized by the addition of 5 mM succi-
nate and after the steady-state distribution of TPP+ has been
reached, Ca2+ (120 nmol/mg protein) was added and Δ=
fluctuations recorded (Custodio et al. 2002). CyA, TAM and
OHTAM were also added during the Δ= depolarization as
indicated in the figure legends.
Measurements of Ca2+ fluxes
Mitochondrial Ca2+ fluxes were evaluated by monitoring the
changes in Ca2+ concentration in the MPT reaction medium
by using a Ca2+-sensitive electrode (Madeira 1975; Cardoso et
al. 2004). The reactions were carried out with mitochondria
(1 mg) in 2 ml of the MPT reaction medium, at 30 °C, in an
open vessel, with a constant stirring. The experiments were
started by the addition of 5 mM succinate 1 min after Ca2+
addition (120 nmol/mg protein), in the absence or in the
presence of isotretinoin (5 nmol/mg protein) (Ca2+ alone).
CyA (1 μM), thiol protecting and antioxidants agents [DTT
(1 mM), NEM (50 μM), Cys (200 μM), NAC (200 μM), Asc
(1 mM) and GSH (1 mM)], ANT ligand [ADP (75 μM)] and
antiestrogenic compounds [TAM and OHTAM (5 μM)] were
added to the reaction medium 3 min prior to the addition of
isotretinoin.
Mitochondrial oxygen consumption
Mitochondria (1 mg) were incubated in 1 ml of standard
respiratory reaction medium (130 mM sucrose, 50 mM KCl,
5 mMMgCl2, 0.1 mM EGTA, 5 mMKH2PO4, 5 mMHepes,
pH 7.4) in the absence or presence of isotretinoin, TAM and
OHTAM. The reactions were performed at 30 °C in a closed
chamber fittedwith a Clark-type oxygen electrode (YSI model
5331, Yellow Spring Inst.) and the drugs were added to the
respiratory medium and incubated with mitochondria for
2 min before starting the reactions. Respiration state 3 was
initiated by the addition of ADP (200 nmol/mg protein), after
energization with 5 mM glutamate/2.5 mM malate or succi-
nate. When succinate was used as the respiratory substrate,
the medium was supplemented with 2 μM rotenone. After
phosphorylation of all the ADP added, the oxygen consump-
tion rate decreased and state 4 respiration was resumed.
The state 4 oligomycin (state 4 olig) was induced by the
addition of oligomycin (1 μg/mg protein) plus ADP to eval-
uate the proton leak through the Fo fraction of complex Vof
the respiratory chain. p-trifluormethoxyphenylhydrazone
(FCCP)-uncoupled respiration was promoted by the addition
of FCCP (1 μM). Respiration rates were calculated assuming
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an oxygen concentration of 240 nmol O2/ml at 30 °C. The
respiratory control ratio (RCR) was calculated by the ratio
between state 3 and state 4 respirations and ADP/O by the
ratio between the amount of ADP added and the O2 consumed
during state 3 respiration, as reported by Chance andWilliams
(Chance & Williams 1956).
HPLC determination of adenylates
Adenine nucleotides (ATP and ADP) were extracted using
an acidic extraction procedure and were separated by
reverse-phase HPLC (Stocchi et al. 1985). The acidic ex-
traction was performed, as follows: mitochondria (1 mg)
were incubated in 1 ml standard respiratory reaction medi-
um (130 mM sucrose, 50 mM KCl, 5 mM MgCl2, 0.1 mM
EGTA, 5 mM KH2PO4, 5 mM Hepes, pH 7.4) in the
absence (control) or in the presence of isotretinoin. After
the incubation period (2 min), 5 mM glutamate/2.5 mM
malate was added to induce the state 2 respiration and,
2 min later, the state 3 respiration was induced by the
addition of 150 nmol ADP. After 1 min reaction, 250 μL
of the suspension were added to 250 μL ice-cooled HClO4
0.6 M (EDTA-Na 25 mM). This mixture was centrifuged at
10 000 rpm for 2 min at 4 °C and the supernatants were
neutralised with KOH 3 M and Tris 1.5 M. The samples
were centrifuged at 10 000 rpm for 2 min and stored at
−80 °C until chromatographic analysis. All the extraction
procedure was carried out at 0–4 °C to minimize degrada-
tion of nucleotides. The chromatographic apparatus used
was a Beckman System Gold, consisting of a 126 Binary
Pump Model and a 166 Variable UV detector controlled by
computer. The protocol used consisted of an isocratic elu-
tion with 100 mM KH2PO4, pH=6.5, and containing 1.2%
methanol. The flow rate was 1 ml/min and the nucleotides
detected at 254 nm (Cardoso et al. 2003; Monteiro et al.
2005).
Determination of active ANT content
Mitochondria (0.5 mg) were incubated in 1 ml of stan-
dard reaction medium (200 mM sucrose, 5 mM KH2PO4,
20 mM Tris–HCl, pH 7.4). The reaction was performed at
30 °C in a closed chamber fitted with a Clark-type oxygen
electrode (YSI model 5331, Yellow Spring Inst.). The active
ANT content (ANT activity) was determined by titrating the
rate of state 3 respiration with increasing concentrations of
carboxyatractyloside (CAT) (Vignais 1976). Mitochondria
were incubated in the absence or presence of isotretinoin and
2 min later CATwas added to mitochondria. After the incuba-
tion period (1 min), the reactions were started by the addition
of 5 mM glutamate/2.5 mMmalate and state 3 respiration was
initiated by adding 0.1 mM ADP. Plots of O2 consumption
versus CAT concentration are biphasic, with an increasing
inhibitory effect followed by a steady-state effect which corre-
sponds to the complete inhibition of state 3 respiration. The
amount of CATcorresponding to complete inhibition of state 3
respiration was used to estimate ANT content assuming a 1:1
binding stoichiometry (Rousseau et al. 2003; Zhou et al.
Fig. 1 Effect of isotretinoin alone or in combination with antiestrogenic
compounds, TAM or OHTAM (a), adenosine nucleotide translocator
(ANT) ligands, ADP or ATP, thiol protecting and antioxidants agents
(b) on mitochondrial permeability transition (MPT) evaluated by the
dissipation of mitochondrial transmembrane potential (Δ=). Additions
of 5 mM succinate (Suc), 120 nmol Ca2+/mg protein (Ca2+), 1 mM
dithiothreitol (DTT), 50 μM N-ethylmaleimide (NEM), 200 μM cysteine
(Cys), 200 μM N-acetylcysteine (NAC), 1 mM ascorbic acid (Asc),
1 mM glutathione (GSH), 75 μM ADP (ADP), 150 μM ATP (ATP),
1 μM cyclosporine A (CyA), 10 nmol TAM/mg protein, 10 nmol
OHTAM/mg protein, before or after energization of mitochondria were
performed as indicated. The traces are representative of four experiments
with different mitochondrial preparations
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2001). The active ANTcontent was expressed as CAT amount
per mg of mitochondrial protein (pmol CAT/mg protein)
(Cardoso et al. 2003; Oliveira & Wallace 2006).
Statistical analysis
The results are expressed as the mean ± SE of four indepen-
dent experiments and data were analysed using one-way
ANOVA analysis of variancewith Tukeymultiple comparison
test. A p-value<0.05 was considered statistically significant.
Results
Effect of antiestrogenic compounds on MPT pore opening
induced by isotretinoin
The Fig. 1a presents the effects of isotretinoin alone or in
combination with TAM or OHTAM on Ca2+-dependent MPT
evaluated by the dissipation of Δ=. In the absence of isotreti-
noin, the addition of Ca2+ (120 nmol/mg protein) to succinate-
energized mitochondria caused a transient depolarization of
Δ= followed by fast repolarization after Ca2+ accumulation,
showing capacity to sustain Δ= (Fig. 1a-Ca2+ alone). In con-
trast, the addition of 200 nmol Ca2+/mg protein caused an
irreversible depolarization of Δ= after Ca2+ addition (results
not shown). The pre-incubation of mitochondria with isotreti-
noin (5 nmol/mg protein or 2.5 μM) caused an irreversible
depolarization of Δ= after addition of 120 nmol Ca2+/mg
protein (Fig. 1a-isotretinoin). The Δ= dissipation induced by
isotretinoin was completely inhibited by CyA (Fig. 1a-CyA), a
specific MPT inhibitor (Broekemeier et al. 1989). The pre-
incubation of mitochondria with 5μMTAMor 5μMOHTAM
(10 nmol/mg protein) afforded complete protection against the
irreversible depolarization induced by isotretinoin (Fig. 1a-
TAM and OHTAM). Moreover, the addition of TAM or
OHTAM during the depolarization of Δ= promoted by isotret-
inoin induced repolarization of Δ= in a similar way to CyA
(Fig. 1a), indicating that these compounds have the ability to
prevent and revert the MPT induced by isotretinoin.
TAM and OHTAM are potent inhibitors of MPT pore
opening probably due to its antioxidants properties (Custodio
et al. 1998; Cardoso et al. 2002b). Therefore, to clarify the
biochemical mechanisms by which MPT pore opening is
potentiated by isotretinoin, we evaluated the effects of thiol
protecting and antioxidants agents that prevent the MPT pore
opening induced by oxidative stress mechanisms. As shown in
Fig. 1b, the pre-incubation of mitochondria with thiol
protecting and antioxidants agents, namely DTT, NEM, Cys,
NAC, Asc and GSH did not prevent the Δ= depolarization
induced by isotretinoin, in contrast to that observed with TAM
and OHTAM (Fig. 1a). However, ANT ligands, ADP or ATP
added to the mitochondria prior to the pre-incubation with
isotretinoin, inhibited the irreversible mitochondrial depolari-
zation (Fig. 1b-ADP and ATP).
The effects of isotretinoin (5 nmol/mg protein) alone or in
combination with TAM andOHTAMwere also investigated on
Ca2+-dependentMPT bymonitoringmitochondrial Ca2+ fluxes
with a Ca2+-electrode (Fig. 2). The energization of mitochon-
dria with succinate induced an accumulation of Ca2+
(120 nmol/mg protein) and mitochondria sustained the accu-
mulated Ca2+ (Fig. 2-Ca2+ alone). The incubation of mitochon-
dria with isotretinoin (5 nmol/mg protein) in the presence of
120 nmol Ca2+/mg protein led to the release of the accumulated
Ca2+ (Fig. 2-isotretinoin). As observed with the TPP+-sensitive
electrode (Fig. 1), CyA prevented the isotretinoin effects on
Ca2+ release (Fig. 2-CyA). Again, the addition of TAM or
OHTAM before or after the MPT induction by isotretinoin
afforded a complete protection against the release of the accu-
mulated Ca2+ (Fig. 2-TAM, OHTAM). However, and similarly
to what was observed with the TPP+-sensitive electrode
(Fig. 1b), the addition of thiol protecting and antioxidant agents
did not prevent the release of the accumulated Ca2+ by mito-
chondria. The addition of ADP, an ANT ligand, before isotret-
inoin and Ca2+ inhibited the release of Ca2+ (Fig. 2-ADP).
Effect of isotretinoin on rat liver mitochondrial
bioenergetics
The effects of isotretinoin were evaluated on oxygen con-
sumption and Δ= of rat liver mitochondria (Figs. 3, 4, 5 and 6).
Fig. 2 Influence of antiestrogenic compounds (TAM or OHTAM) and
ADP on isotretinoin–induced mitochondrial permeability transition
(MPT) evaluated by mitochondrial Ca2+ fluxes. Additions of 5 mM
succinate (Suc), 120 nmol Ca2+/mg protein (Ca2+), 75 μM ADP
(ADP), 1 μM cyclosporine A (CyA), 10 nmol TAM/mg protein,
10 nmol OHTAM/mg protein, before or after energization of mito-
chondria were performed as indicated. The traces are representative of
four independent assays with different mitochondrial preparations
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Isotretinoin pre-incubated with mitochondria energized
with glutamate/malate significantly decreased the state 3
respiration in a concentration dependent way (Fig. 3a). At
5 and 10 nmol/mg protein (5–10 μM) isotretinoin did not
induce statistically significant alterations in the state 4 res-
piration, but 20 nmol isotretinoin/mg protein significantly
stimulated the state 4 respiration (Fig. 3a). The addition of
ADP and oligomycin (state 4 oligomycin) to mitochondria
pre-incubated with 5 and 10 nmol isotretinoin/mg protein
induced a decrease in the state 4 oligomycin, though
without statistical significance. At higher concentrations
(≥ 20 nmol/mg protein), the addition of oligomycin decreased
the oxygen consumption stimulated by isotretinoin (Fig. 3a).
FCCP-uncoupled respiration was significantly decreased
above 10 nmol isotretinoin/mg protein (Fig. 3a). The effects
of isotretinoin on the respiration rates, supported by succinate
(Fig. 3b), were slightly different from those observed with
glutamate/malate (Fig. 3a). As presented in Fig. 3b, the state
4 respiration was significantly stimulated at concentrations
above 10 nmol isotretinoin/mg protein (Fig. 3a). State 3 was
not significantly affected by 5 nmol isotretinoin/mg protein
and at concentrations above 10 nmol isotretinoin/mg protein
the effects were less pronounced than in glutamate/malate
supported respiration (Fig. 3b). Concerning FCCP-uncoupled
respiration, we found that isotretinoin did not significantly
affect this parameter at concentrations bellow 20 nmol
isotretinoin/mg protein in mitochondria energized with succi-
nate (Fig. 3b). Moreover, at concentrations of 20 nmol
isotretinoin/mg protein the FCCP-uncoupled respiration was
less affected (Fig. 3b), as compared with energization with
glutamate/malate (Fig. 3a).
In mitochondria energized with glutamate/malate (Fig. 4a)
the RCR and ADP/O indices were also slightly different from
those observed with succinate (Fig. 4b). The addition of
5 nmol isotretinoin/mg protein tomitochondria energized with
glutamate/malate induced a significant decrease in RCR
(Fig. 4). In the presence of higher concentrations of isotretinoin
FCCP
St3
St4
St4 olig
a
b
Fig. 3 Effect of isotretinoin on (a) glutamate/malate- and (b) succi-
nate-supported respiration. O2 consumption rates of rat liver mitochon-
dria in state 3 (closed circles), state 4 (open triangles), state 4
oligomycin (state 4 olig) (closed triangles) and FCCP-uncoupled res-
piration (closed squares). Results are presented as the mean ± SE for
the four experiments obtained from different mitochondrial prepara-
tions (when the error bars are not visible, SE is obscured by the size of
the symbols). ***p<0.001, **p<0.01 and *p<0.05 when compared
with the control (in the absence of isotretinoin) in state 3 respiration.
$$$p<0.001 vs the respective control in state 4 respiration; ###p<0.001
and ##p<0.01 vs control in FCCP-uncoupled respiration. ++p<0.01 and
+p<0.05 when state 4 olig is compared with state 4 respiration
Fig. 4 Effect of isotretinoin on (a) glutamate/malate- and (b) succi-
nate-supported respiration indices: respiratory control ratio (RCR)
(closed circles) and ADP/O (open circles). Results are presented as
the mean ± SE of four experiments obtained from different mitochon-
drial preparations (when the error bars are not visible, SE is
encompassed by the size of the symbols). ***p<0.001, **p<0.01
and *p<0.05 when compared with the respective control (in the ab-
sence of isotretinoin)
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(>10 nmol/mg protein) this decrease was much more pro-
nounced, as compared to control conditions (Fig. 4a), mainly
due to the decrease in state 3 respiration. At concentrations of
isotretinoin above 20 nmol/mg protein, the RCR ratio ap-
proaches 1.0 (Fig. 4a), suggesting that the phosphorylation of
ADP did not occur due to an uncoupling effect on mitochon-
drial respiration. The ADP/O index was also decreased and for
20 nmol isotretinoin/mg protein we were not able to determine
the ADP/O ratio, because mitochondria were uncoupled, as
shown by the RCR index (Fig. 4a). In mitochondria energized
with succinate (Fig. 4b), the RCR was not significantly affect-
ed by 5 nmol isotretinoin/mg protein and it was less decreased
at concentrations of 10 nmol isotretinoin/mg protein (Fig. 4b).
However, this decrease is mainly a consequence of the stimu-
lation of state 4 (Fig. 3b), since the state 3 respiration was less
diminished when compared with mitochondria energized with
glutamate/malate. Additionally, the RCR approaches a value
of 2.0 for concentrations above 20 nmol isotretinoin/mg
protein (Fig. 4b), meaning that mitochondria are not complet-
ed uncoupled, as observed with glutamate/malate (Fig. 4a).
Relatively to the ADP/O, we found that this index was also
decreased at concentrations above 10 nmol isotretinoin/mg
protein (Fig. 4b), but the phosphorylative capacity of hepatic
mitochondria in the presence of succinate was less affected than
in mitochondria energized with glutamate/malate (Fig. 4a).
The depressive effect of isotretinoin on the phosphoryla-
tion capacity of mitochondria was further evaluated by fol-
lowing the Δ= fluctuations associated with the phosphoryla-
tion cycle induced by ADP (Figs. 5 and 6). After the addition
of glutamate/malate (Fig. 5), in the absence of isotretinoin,
mitochondria developed a Δ= of about 219.9±1.3 mV
(negative inside). The addition of isotretinoin at concentra-
tions of 5 and 10 nmol/mg protein did not significantly affect
the mitochondrial Δ=. However, at 20 nmol isotretinoin/mg
protein, we found a significant decrease in the Δ= (Fig. 5).
The addition of ADP in the absence of isotretinoin dropped
the Δ= in 25.1±1.6 mV (ADP depolarization). The pre-
incubationwith isotretinoin at concentrations above 10 nmol/mg
protein decreased the ADP depolarization (Fig. 5). The time
required for the phosphorylation of ADP (lag phase) in the
absence of isotretinoin was 63.4±1.7 s, while the addition
of 5 and 10 nmol isotretinoin/mg protein induced a significant
increase (Fig. 5). At 20 nmol isotretinoin/mg protein the lag
phase was not measured since the phosphorylation of ADP
did not occur in agreement with the RCR index (Fig. 4a).
When ADP phosphorylation occurred, the repolarization and
Fig. 5 Effect of isotretinoin on
glutamate/malate-dependent
transmembrane potential (Δ=)
of rat liver mitochondria. The
traces represent typical records
from experiments performed in
the conditions described in
“Material and Methods”. The
arrows indicate the additions of
5 mM glutamate/2.5 mM
malate (Glu/Mal), 150 nmol
ADP/mg protein (ADP), and
the numbers on the right to the
traces are the concentrations of
isotretinoin. Data in the table
below, present the mean ± SE of
four experiments obtained from
different mitochondrial
preparations. ***p<0.001,
**p<0.01 and *p<0.05 vs
control (in the absence of
isotretinoin)
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the transmembrane potential returned to the initial value
(−219.6±1.0 mV). In the presence of 5 and 10 nmol/mg pro-
tein, isotretinoin did not change the potential repolarization. At
concentrations above 20 nmol isotretinoin/mg protein the repo-
larization did not occur and mitochondria had no capacity to
sustain the Δ= (Fig. 5).
In mitochondria energized with succinate (Fig. 6), the
results were slightly different, when compared with those
observed with glutamate/malate (Fig. 5). In fact, the lag
phase of phosphorylation cycle was only significantly af-
fected at concentrations above 10 nmol isotretinoin/mg pro-
tein in mitochondria energized with succinate (Fig. 6), while
5 nmol isotretinoin/mg protein decreased the lag phase in
mitochondria energized with glutamate/malate (Fig. 5). On the
contrary, in mitochondria energized with glutamate/malate, the
Δ= developed after the addition of 20 nmol isotretinoin/mg
protein was not affected (Fig. 6). Furthermore, at 30 nmol
isotretinoin/mg protein, mitochondria energized with succinate
had the capacity to maintain theΔ= after the addition of ADP
(data not shown), in contrast to that observed in mitochondria
pre-incubated with 20 nmol isotretinoin/mg protein and ener-
gized with glutamate/malate.
Effect of isotretinoin on the active ANT content
The active ANTcontent (ANTactivity) was also determined to
clarify the MPT pore opening and the changes in the mito-
chondrial phosphorylation induced by isotretinoin (Fig. 7).
The mitochondrial content of active ANT was determined by
the amount of CAT required to reduce state 3 respiration to the
Fig. 6 Effect of isotretinoin on
succinate-dependent
transmembrane potential (Δ=)
of rat liver mitochondria. The
traces represent typical records
from experiments performed in
the conditions described in
“Material and Methods”. The
arrows indicate the additions of
5 mM succinate (Suc),
150 nmol ADP/mg protein
(ADP), and the numbers on the
right of the traces are the
concentrations of isotretinoin.
Data in the table below, present
the mean ± SE of the
transmembrane potential at the
different concentrations of
isotretinoin. ***p<0.001 and
*p<0.05 vs control (in the
absence of isotretinoin)
Fig. 7 Effect of isotretinoin on mitochondrial active adenine nucleo-
tide translocase (ANT) content. The experiments were performed out
as described in “Material and Methods” and data are expressed as pmol
carboxyatractyloside (CAT) per mg of mitochondrial protein. The
values are present as the mean ± SE of four different experiments,
using different mitochondrial preparations. ***p<0.001 and **p<0.01
vs control (in the absence of isotretinoin)
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state 4 respiration rate, when CAT saturates the translocase
sites (Vignais 1976). In the absence of isotretinoin, the ANT
was only inhibited by the addition of 468 pmol CAT/mg
protein. However, in the presence of 5 and 10 nmol
isotretinoin/mg the active ANTcontent was decreased to about
222 and 97 pmol CAT/mg protein, respectively (Fig. 7), which
corresponds to approximately 47% and 21% of the control. At
20 nmol/mg protein, isotretinoin inhibited almost completely
the active ANT content, suggesting that isotretinoin interferes
with the ANT in a concentration dependent way.
Effect of isotretinoin combined with antiestrogens
on mitochondrial phosphorylation efficiency
Besides the inhibition of isotretinoin-induced MPT (Figs. 1
and 2), the effects of isotretinoin in combination with OHTAM
Fig. 8 Effect of isotretinoin alone (5 nmol/mg protein) or in combination
with antiestrogenic compounds (10 nmol/mg protein) on glutamate/ma-
late- supported respiration. The rates of O2 consumption (a) in state 3, (b)
state 4 and state 4 oligomycin (state 4 olig), (c) FCCP-uncoupled respi-
ration, and the respiration indices, (d) respiratory control ratio (RCR) and
(e) ADP/O of rat liver mitochondria, are shown. Results are presented as
the mean ± SE of four experiments using from different mitochondrial
preparations. ***p<0.001, **p<0.01 and *p<0.05 when compared with
the control (in the absence of isotretinoin) conditions. +++p<0.001, ++p<
0.01 when compared with isotretinoin alone
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or TAM were also evaluated on respiratory chain (Fig. 8) and
on the energetic levels (Table 1) of mitochondria.
The combination of 5 nmol isotretinoin/mg protein (5 μM)
with OHTAM or TAM (10 nmol/mg protein or 10 μM) in-
duced a significant decrease in state 3 respiration (Fig. 8a).
However, this decrease was not statistically significant when
compared with isotretinoin alone (5 nmol/mg protein) that was
able to induce a decrease in state 3. The state 4 respiration was
not significantly stimulated when isotretinoin was combined
with OHTAM (Fig. 8b). On the contrary, isotretinoin in com-
bination with TAM induced a significant increase in state 4
respiration, as compared to the control and isotretinoin alone.
The fact that the addition of oligomycin did not decrease the
oxygen consumption stimulated by TAM combined with iso-
tretinoin (Fig. 8b) suggests that the state 4 stimulation induced
by this association is not due to proton leak through Fo fraction
of complex V of the respiratory chain. By monitoring the
changes in the FCCP-uncoupled respiration (Fig. 8c), we
found that the studied associations did not inhibit the respira-
tory chain activity. In agreement with the results obtained for
state 3 and state 4 respiration, the combination of isotretinoin
with OHTAM did not decrease significantly the RCR ratio
(Fig. 8d). However, the combination of isotretinoin with TAM
induced a significant decrease in the RCR value (Fig. 8d), as a
consequence of the stimulation of state 4 respiration (Fig. 8b).
The ADP/O ratio was not changed by the combination of
isotretinoin with OHTAM or TAM (Fig. 8e).
The effects of isotretinoin alone or in combination with either
TAM or OHTAM on the mitochondrial energetic levels were
also determined by evaluating the ATP and ADP contents by
HPLC (Table 1). The addition of 5 nmol isotretinoin/mg protein
(5 μM) induced a significant decrease in the ATP levels, while
the ADP levels increased. These effects were more pronounced
in the presence of higher concentrations of isotretinoin
(≥10 nmol/mg protein) (Table 1), suggesting that phosphoryla-
tion is compromised, according to the RCR index (Fig. 54a) and
to the phosphorylation cycle (Figs. 3a and 5). Interestingly, the
co-incubation of mitochondria with isotretinoin (5 nmol/mg
protein) and TAM or OHTAM (10 nmol/mg protein) did not
induce significant changes in the ATP and ADP levels (Table 1),
and the values were similar to those observed in the presence of
both antiestrogens individually (data not shown), as previously
reported (Cardoso et al. 2003).
Discussion
This study demonstrates that isotretinoin is an effective induc-
er of the Ca2+-dependentMPT pore opening (Figs. 1 and 2), in
agreement with Rigobello et al. (1999). In our experimental
conditions, isotretinoin promoted MPT pore opening at
5 nmol/mg protein (2.5 μM), which is lower than the concen-
tration used by Rigobello et al. (1999) (4 to 33 μM or 16 to
132 nmol/mg protein). Isotretinoin at 5 nmol/mg protein did
not affect the respiratory chain (Figs. 3 and 4), and did not
alter the Δ= developed by mitochondria (Figs. 5 and 6).
Moreover, the depolarization of Δ= and the release of Ca2+
associated to MPT induction by 5 nmol isotretinoin/mg pro-
tein were reverted by the addition of CyA after the pore
opening (Figs. 1 and 2), suggesting that isotretinoin is directly
affecting the conformational structure of the constituents of the
mega protein complex comprising the MPT pore. Isotretinoin
changed significantly the mitochondrial respiration and the
oxidative phosphorylation only at concentrations higher than
5 nmol/mg protein (Figs. 3, 4, 5 and 6) (Table 1). The modu-
lation of the MPT has been associated with the orientation of
the ADP/ATP translocase across the inner membrane. Our data
strengthens this hypothesis, as we found that isotretinoin at
concentrations higher than 5 μM strongly alters the active
ANT content (ANT activity) (Fig. 7).
Our study demonstrated that the isotretinoin-induced Ca2+-
dependentΔ= depolarization (Fig. 1) and Ca2+ release (Fig. 2),
due to MPT promotion, were prevented and reverted by TAM
and OHTAM, suggesting that both antiestrogens are inhibitors
of the MPT pore opening induced by isotretinoin. It has been
documented that the MPT induction may occur following an
Table 1 Effect of isotretinoin alone or combined with TAM or OHTAM on the levels of ATP and ADP in liver mitochondria respiring glutamate/
malate. Data correspond to the mean ± SEM of four independent experiments with different mitochondrial preparations
Isotretinoin
(nmol/mg protien)
TAM/OHTAM
(nmol/mg protien)
ADP
(nmol/mg protien)
ATP
(nmol/mg protien)
0 – 9.3±2.2 126.3±8.3
5 – 16.6±1.4** 102.2±1.7**
10 – 334.±3.6*** 72.7±1.7***
20 – 51.6±3.2*** 40.3±10.9***
–
5 10 TAM 12.8±3.4 166.3±6.2
5 10 OHTAM 12.8±3.4 119.6±8.1
***p<0.001 and **p<0.01 when compared with the respective control (in the absence of isotretinoin).
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oxidative stress event (Halestrap et al. 1997). In opposition to
TAM and OHTAM, known as intramembranous antioxidants
(Custodio et al. 1994), the addition of thiol protecting and
antioxidant agents (DTT, NEM, Cys, NAC, Asc and GSH)
did not prevent the MPT pore opening induced by isotretinoin
(Figs. 1b and 2). Thus, the use of these compounds that are
effective inhibitors of permeability transition, demonstrates
that isotretinoin-induced MPT cannot be related to oxidative
alterations of the mitochondrial proteins of the MPT pore.
ANT ligands, such as ATP and ADP, prevented the MPT pore
opening induced by isotretinoin (Figs. 1b and 2). Both adenine
nucleotides inhibited pore opening by binding to both high-
and low-affinity sites of the ANT, preventing calcium from
inducing the cyclophilin-D-mediated conformational change
(Halestrap & Pasdois 2009). Isotretinoin can induce the MPT
through an interaction with the mitochondrial cyclophilin-D
and the adenine nucleotide translocator, which is in accordance
with the effects obtained by titration of mitochondria with
carboxyatractyloside (Fig. 7). Noteworthy, photoaffinity label-
ing studies have demonstrated that tretinoin (all-trans-retinoic
acid) directly binds to the ANT (Notario et al. 2003). We may,
therefore, propose that as occurs with carboxyatractyloside,
isotretinoin can promote pore opening by stabilizing ANT in
the cytosolic side of the inner membrane. Our hypothesis
seems to be in agreement with the inhibition of the MPT by
TAM and OHTAM. As the antiestrogens do not significantly
affect the active ANT content at the concentrations used to
inhibit isotretinoin-induced MPT (Cardoso et al. 2003), it is
plausible that the antiestrogens, which strongly partition in
the core of biomembranes (Custodio et al. 1991), prevent the
MPT induced by isotretinoin through the decrease of membrane
fluidity (Custodio et al. 1993; Kazanci & Severcan 2007). This
effect would indirectly compromise the activity of membrane
proteins, such as the ANT. These multiple mechanisms of anti-
estrogens may prevent the conformational changes promoted by
isotretinoin, which are involved in the MPT induction.
Isotretinoin-induced changes observed inmitochondrial func-
tions and in different cancer cell lines (Arce et al. 2005;
Guruvayoorappan et al. 2008; Vuletic et al. 2010) were also
observed with other drugs (Kass 2006) and may explain some
side effects described in patients treated with isotretinoin
(Goodfield et al. 2010; Sardana & Garg 2011). Thus, the asso-
ciation of TAM or OHTAM with isotretinoin therapy may be
crucial to reduce or avoid the adverse effects observed in
monotherapy with isotretinoin. Moreover, the interaction of
isotretinoin with the ANT, a regulatory element of theMPT pore
(Pebay-Peyroula &Brandolin 2004; Zorov et al. 2009), suggests
a possible mechanism for MPT pore induction and may also
explain the decrease in state 3 respiration (Fig. 3a) since, as
reported above, isotretinoin at 5 nmol/mg protein did not induce
any other change responsible for this effect (Figs. 3, 4, 5 and 6).
Our study also showed that isotretinoin induced more
significant changes in different mitochondrial functions at
concentration above 10 nmol/mg protein. In fact, isotretinoin
depressed the phosphorylation capacity of hepatic mitochon-
dria, as shown by the decrease in state 3 respiration (Fig. 3a),
RCR, ADP/O indices (Fig. 4a), ATP levels (Table 1) and by
the increase in the lag phase of ADP phosphorylation cycle
(Fig. 5). Nevertheless, isotretinoin at this concentration slight-
ly affected the respiratory chain, as suggested by its effect on
FCCP-uncoupled respiration (Fig. 3a), and in the membrane
potential developed by mitochondria (Fig. 5). However, the
results demonstrated that isotretinoin significantly decreased
the ANT content (Fig. 7), indicating that the interaction with
this component of the phosphorylation system, may be the
main factor involved in the decrease of mitochondrial phos-
phorylative efficiency induced by isotretinoin. At higher con-
centrations (≥ 10 nmol/mg protein) isotretinoin significantly
potentiated the mitochondrial dysfunctions described above
and uncoupled the mitochondrial respiration as inferred from
the decrease in the respiratory control ratio (Fig. 3a), ADP/O
index (Fig. 4a) and from the effects on the ADP phosphory-
lation cycle (Fig. 5). This effect is probably due to the strong
changes induced in the active ANT content (Fig. 7) and to
its ability to affect the conformational structure of complex V
proteins, namely the fraction Fo of ATP synthase, inducing leak
of protons as evidenced by the effects on state 4 oligomycin
(Fig. 3a) and by the decrease in Δ= (Fig 5). The inhibitory effect
on the respiratory chain complex I is inferred from the signifi-
cant decrease in the FCCP-uncoupled respiration (Fig. 3a)
and the Δ= developed by mitochondria energized with
glutamate/malate (Fig. 5), as comparedwith the slight changes
induced in mitochondria energized with succinate (Figs. 3b
and 6). This inhibitory effect on respiratory complex I also
contributes to the impairment of mitochondria promoted by
high concentrations of isotretinoin. It is possible that these
mitochondrial dysfunctions may underlie or contribute to the
numerous side effects observed in patients treated with high
isotretinoin concentrations (Goodfield et al. 2010; Sardana &
Garg 2011). Thus, the combination of isotretinoin with other
compounds would be an important therapeutic approach, by
promoting an additive/synergistic therapeutic action and an
important improvement in patient’s quality of life, as the use
of lower concentrations of each compound would lead to a
reduction in the adverse side effects.
When we combined low concentrations of isotretinoin
(5 nmol/mg protein) with TAM or OHTAM (10 nmol/mg
protein), besides the protective effect observed in the MPT
pore opening, no significant changes were observed in the
oxidative phosphorylation system and in the respiratory
chain (Fig. 8), as compared with isotretinoin alone. An
exception was observed when isotretinoin was combined
with TAM, occurring a stimulation of the state 4 that is
possibly due to the permeabilization of the inner mitochon-
drial membrane to protons, induced by TAM, as previously
described by Cardoso et al. (2001). Moreover, TAM and
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OHTAM, which at the concentrations tested did not change
the mitochondria phosphorylation efficiency (Cardoso et al.
2003), promoted a reduction in the ATP depletion induced
by isotretinoin (Table 1). The prevention of isotretinoin-
induced MPT by both antiestrogens (Figs. 1 and 2), may
rely on the fact that TAM and OHTAM lock the ANT on the
mitochondrial membrane, diminishing the interaction of
isotretinoin with the adenine nucleotide carrier or competing
for the binding sites of isotretinoin in the ANT.
Our data show that isotretinoin induces different dysfunc-
tional changes in mitochondria. These mitochondrial dysfunc-
tions include an increase in the sensitivity of mitochondria to
Ca2+-inducedMPT, which is prevented by TAM and OHTAM,
and bioenergetic damaging effects. Mitochondrial dysfunction
is a triggering event for cell toxicity and death, due to their
crucial role in cell homeostasis. Our studies in mitochondria
suggest that isotretinoin-associated liver toxicity and apoptosis
is possibly related with mitochondrial dysfunctions due to in-
teractions with the ANT. The abnormalities in liver functions
and systemic side effects observed in patients treated with this
retinoid (Erturan et al. 2012) may be related with the mitochon-
drial damage described since the concentrations of isotretinoin
used in our experiments (5–10 nmol/mg protein or 5–10 μM)
correspond to those that are usually achieved in blood with
therapeutic doses of 160 mg/m2/day (7.2±5.3 μM) (Erturan et
al. 2012; Veal et al. 2007), although different studies indicated a
>10-fold inter-patient variation in plasma concentrations.
Plasma concentrations above 10 μM were correlated with an
increased incidence of hepatic toxicity, hyperkaliemia and
hipercalcemia (Erturan et al. 2012). Therefore, we propose that
the use of isotretinoin combined with OHTAM can reduce the
side effects on proteins responsible for Ca2+ homeostasis and
energy production in the cell. Further in vivo studies are re-
quired to clarify the toxicity and safety of the combination of
isotretinoin with antiestrogens in humans, in order to establish
the therapeutic efficacy of this therapy.
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